Zynex rises on report firm weighing options including possible sale

Zynex

30/10/2023 22:15

** Shares of medical device maker Zynex  ZYXI.O  up 5% at
$8.99 in extended trading
    ** Zynex has initiated a process to review potential
strategic alternatives including selling itself, Bloomberg News
says, citing people familiar with the matter
    ** Adds co working with financial services firm Cantor
Fitzgerald to evaluate options, which may include any
take-private offers, a merger, divestiture, recapitalization or
any other transaction
    ** As of last close, stock had fallen 38.2% YTD

 (Reporting by Granth Vanaik in Bengaluru)
 ((Granth.Vanaik@thomsonreuters.com; Twitter: https://twitter.com/Vanaik_Granth;))